InsidersTradesSigma
Explore the complete record of transactions filed by McKenna Mark C., Chief Executive Officer. Insider active across 1 companies, notably Prometheus Biosciences, Inc.. Aggregated, 2 filings have been recorded. The latest transaction was disclosed on 1 December 2021 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations
Mark C. McKenna is the Chief Executive Officer at Prometheus Biosciences, Inc. He oversees the company's operations and is responsible for implementing the overall strategy. His leadership is crucial for the company's success.